Global Custom Recombinant Protein Production Service Market Growth (Status and Outlook) 2026-2032

The global Custom Recombinant Protein Production Service market size is predicted to grow from US$ 1454 million in 2025 to US$ 2112 million in 2032; it is expected to grow at a CAGR of 5.5% from 2026 to 2032.

Custom recombinant protein production service is a personalized biotechnology outsourcing service that provides tailored protein development and manufacturing according to client requirements; relying on genetic engineering, microbial fermentation, mammalian cell culture, protein purification and quality control technologies, it covers the whole process from gene synthesis, vector construction, host cell expression system screening, large-scale culture, protein purification to endotoxin removal and lyophilization preparation, supplying high-purity, customized recombinant proteins for scientific research, drug development, in vitro diagnosis and biological product development, and meeting non-standard, targeted protein preparation demands that cannot be satisfied by commercial off-the-shelf products.

The industry is trending toward GMP-compliant clinical-grade production, AI-assisted gene sequence optimization, high-density cell culture and integrated one-stop CRO/CDMO services, gradually shifting from laboratory-scale research services to commercial-scale manufacturing; opportunities are driven by the rapid development of antibody drugs, therapeutic proteins, mRNA vaccines, cell therapy and in vitro diagnostic reagents, continuous growth in global biomedical R&D investment, and the rising outsourcing rate of protein production among pharmaceutical enterprises and research institutions; meanwhile, the sector faces challenges including high technical barriers for difficult-to-express proteins, strict requirements for product stability and batch consistency, high costs of GMP production line construction and quality control, risks of gene sequence confidentiality and intellectual property disputes, and pressure to shorten delivery cycles while controlling production costs.

LPI (LP Information)' newest research report, the “Custom Recombinant Protein Production Service Industry Forecast” looks at past sales and reviews total world Custom Recombinant Protein Production Service sales in 2025, providing a comprehensive analysis by region and market sector of projected Custom Recombinant Protein Production Service sales for 2026 through 2032. With Custom Recombinant Protein Production Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Custom Recombinant Protein Production Service industry.

This Insight Report provides a comprehensive analysis of the global Custom Recombinant Protein Production Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Custom Recombinant Protein Production Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Custom Recombinant Protein Production Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Custom Recombinant Protein Production Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Custom Recombinant Protein Production Service.

This report presents a comprehensive overview, market shares, and growth opportunities of Custom Recombinant Protein Production Service market by product type, application, key players and key regions and countries.

Segmentation by Type:
Mammalian Cell Based
Bacteria Based
Insect Cell Based
Others

Segmentation by Production Scale:
Laboratory Micro-Scale Service
Pilot Medium-Scale Service
Commercial Large-Scale Service

Segmentation by Application:
Basic Scientific Research
Monoclonal Antibody Drug Development
Therapeutic Protein Production
Mrna Vaccine Research
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
VectorBuilder
Proteos
Creative Biolabs
Charles River
InVivo BioTech Services GmbH
eEnzyme
BiologicsCorp
Biomatik
RayBiotech
R&D Systems
OriGene Technologies
Applied Biological Materials Inc. (abm)
Creative BioMart
Levprot Bioscience
Jubilant Biosys
Kinexus Bioinformatics
NorthX Biologics
Leinco Technologies
GenScript
KACTUS
G &P Biosciences
Boster Bio
Eurofins Discovery

Please note: The report will take approximately 2 business days to prepare and deliver. Show more